Clarithromycin as inherent component of anti-helicobacter therapy
The article is devoted to the review of current treatment regimens of Helicobacter pylori infection and place them clarithromycin. Current recommendations of international consensus Maastricht II-III are presented. We discussed the possible ways to solve the main problems associated with increasing antibiotic resistance of H. pylori. The basic reasons for its development are stated. Particular attention is paid to the prospects of new regimens, in particular the eradication treatment regimen with clarithromycin administration, and to the quality of antibacterial drugs.

Keywords: generics, microbial resistance, clarithromycin, antihelicobacter therapy, eradication, Helicobacter pylori